Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Public Citizen petitions FDA for new warning about long-term use of Plavix in stent patients
Yahoo/AP
Wednesday, August 21, 2013 - 10:11am
tags:
FDA, Plavix, Public Citizen, Sanofi, Bristol-Myers Squibb
Report Outlines Arena's European Prospects
Seeking Alpha
Wednesday, August 21, 2013 - 9:47am
tags:
Arena Pharmaceuticals, Belviq, Orexigen, Europe, Eisai
Forest Labs: Will You Invest In This Game Changer Antidepressant?
Seeking Alpha
Wednesday, August 21, 2013 - 9:46am
tags:
antidepressants, Forest Labs, Pfizer, Eli Lilly, Fetzima
Cholesterol drugs will continue to be market leader for a decade: report
Marketwatch
Wednesday, August 21, 2013 - 9:43am
tags:
dyslipidemia, statins
J&J Said to Weigh $3 Billion Settlement of Its Hip Implant Cases
Bloomberg
Wednesday, August 21, 2013 - 9:11am
tags:
settlements, JNJ, hip implants, devices
Does Merck Need A Major Restructuring?
Forbes
Wednesday, August 21, 2013 - 9:06am
tags:
Merck, restructuring
"Breakthrough Therapy" Status Could Hasten Novartis Drug Review
Motley Fool
Wednesday, August 21, 2013 - 9:05am
tags:
Novartis, breakthrough therapies, BYM338, sporadic inclusion body myositis, FDA
3 New Diabetes Drugs Possibly on the Way Soon
Motley Fool
Wednesday, August 21, 2013 - 9:03am
tags:
diabetes, Forixga, AstraZeneca, Bristol-Myers Squibb, dulaglutide, Eli Lilly, Afrezza, MannKind
These drugs are the cash cows of big pharma
Quartz
Tuesday, August 20, 2013 - 12:20pm
tags:
JNJ, Novartis, Pfizer, Merck, Roche, Bayer, Sanofi, GSK, Abbott Labs, AstraZeneca, Eli Lilly
Adimab adds Celgene to high-profile clientele for antibody drug discovery
Fierce Biotech
Tuesday, August 20, 2013 - 12:17pm
tags:
Adimab, Celgene, antibody discovery
Multiple Sclerosis market to reach more than $18bn by 2018
Datamonitor Healthcare
Tuesday, August 20, 2013 - 12:13pm
tags:
MS, multiple sclerosis, Biogen Idec, Tecfidera
AEterna Zentaris: An Interesting Investment With Long-Term Growth Potential
Seeking Alpha
Tuesday, August 20, 2013 - 11:58am
tags:
Aeterna Zentaris, AEZS-130
Allergan climbs after countering FDA draft on generic drug testing
The Fly on the Wall
Tuesday, August 20, 2013 - 11:56am
tags:
Allergan, FDA, generics, Restasis
Analyst to Merck: Get to work chopping costs, preferably $1B-plus
Fierce Pharma
Tuesday, August 20, 2013 - 10:44am
tags:
Merck
Anacor: Overvalued On Weak Drug Pipeline
TheStreet.com
Tuesday, August 20, 2013 - 10:25am
tags:
Anacor, Valeant Pharmaceuticals, AN2728, Tavaborole
China Biologic Products: What Happens When You Know Demand Will Double In 3 Years
Seeking Alpha
Tuesday, August 20, 2013 - 10:24am
tags:
China Biologic, plasma-based pharmaceuticals
Seeking Oncologists' Attention — More Ads, Fewer Reps
Medscape
Tuesday, August 20, 2013 - 9:21am
tags:
oncologists, drug reps, drug ads
Merck & Co. Ups Russian Contract to Appease Pharma 2020
Outsourcing Pharma
Tuesday, August 20, 2013 - 9:19am
tags:
Merck, Russia, drug manufacturing
Eisai Sues DEA Over Delay In Scheduling Its Epilepsy Drug
Pharmalot
Tuesday, August 20, 2013 - 9:17am
tags:
Eisai, DEA, epilepsy, Fycompa
Sequenom cuts 75 jobs in reorganization plan
Yahoo/AP
Tuesday, August 20, 2013 - 9:14am
tags:
Sequenom, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.